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Purpose: The objective of the present investigation was to evaluate the morphologic 
  characteristics of self-assemblies of diamond (nano-D), silver (nano-Ag), gold (nano-Au), and 
platinum (nano-Pt) nanoparticles with Staphylococcus aureus (bacteria) and Candida albicans 
(fungi), to determine the possibility of constructing microorganism–nanoparticle vehicles.
Methods: Hydrocolloids of individual nanoparticles were added to suspensions of S. aureus 
and C. albicans. Immediately after mixing, the samples were inspected by transmission electron 
microscopy.
Results: Visualization of the morphologic interaction between the nanoparticles and microor-
ganisms showed that nano-D, which are dielectrics and exhibit a positive zeta potential, were 
very different from the membrane potentials of microorganisms, and uniformly surrounded the 
microorganisms, without causing visible damage and destruction of cells. All metal nanoparticles 
with negative zeta potential had cell damaging properties. Nano-Ag showed the properties of 
self-organization with the cells, disintegrating the cell walls and cytoplasmic membranes, and 
releasing a substance (probably cytoplasm) outside the cell. Arrangement of nano-Au with micro-
organisms did not create a system of self-organization, but instead a “noncontact” interaction 
between the nanoparticles and microorganisms was observed to cause damage to fungal cells. 
Nano-Pt caused both microorganisms to release a substance outside the cell and disintegrated 
the cytoplasmic membrane and cell wall.
Conclusion: Nano-Ag, nano-Au, and nano-Pt (all metal nanoparticles) are harmful to bacteria 
and fungi. In contrast, nano-D bind closely to the surface of microorganisms without causing 
visible damage to cells, and demonstrating good self-assembling ability. The results indicate 
that both microorganisms could be used as potential carriers for nano-D.
Keywords: nanoparticles, diamond, silver, gold, platinum, Staphylococcus aureus, Candida 
albicans, morphology
Introduction
Targeted drug transport methods are key techniques being searched for in medicine. 
Cancer therapy, in particular, requires new technology to deliver drugs precisely, 
to be nontoxic to other tissues, with the possibility of sustained release of active 
substances, and to target cells. Microorganisms possess an extraordinary potential 
to move, survive safely, and settle in precisely programmed regions of the body.1–3 
Staphylococcus aureus exfoliates epidermal layers and localizes within the skin,4 and 
can also penetrate lungs, bloodstream, joints, and bones.5–10 Candida albicans lives on 
75% of the human population and is commonly found in the gastrointestinal tract, oral 
cavity, and genital area, with no harmful effects.11 However, when body resistance 
is low, as in leukemia, autoimmune deficiency syndrome, or in transplant recipients, International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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C. albicans can enter the bloodstream and penetrate different 
organs, causing serious infections.12–15
It is well known that inorganic nanoparticles can act as 
antibacterial and antifungal agents, and thus have the abil-
ity to interact with microorganisms.16–20 However, prior to 
using microorganisms as a mean of transport for bioactive 
molecules, such as nanoparticles or drugs linked to nanopar-
ticles, it is essential to investigate how to deposit the mol-
ecules within microorganisms. It has already been described 
how Gram-negative bacteria can be used for constructing 
bacterial ghosts, representing novel advanced delivery and 
targeting vehicles suitable for the delivery of hydrophobic 
or water-soluble drugs.2,21 Also, in pathogenic fungi, like C. 
albicans, several components associated with the cell wall 
have been identified to play an important role in fungal–host 
interactions.22
We have previously demonstrated that by simple mix-
ing of nanoparticles of gold and platinum with Salmonella 
  enteritidis and Listeria monocytogenes, a process of self-
assembly takes place, but with different morphologic interac-
tions depending on the bacteria and nanoparticles used.23 In 
the present investigation, other microorganisms and additional 
nanoparticles were chosen to elucidate further the possibilities 
for constructing microorganism–nanoparticle vehicles.
Exerting their antibacterial properties, silver nanoparticles 
(nano-Ag) attach and anchor to the surface of the cell. This 
interaction causes structural changes and damage, markedly 
disturbing vital cell functions, such as permeability, causing 
pits and gaps, depressing the activity of respiratory chain 
enzymes, and finally leading to cell death.20,24–28 Nano-Ag also 
inhibit yeast growth29,30 and have antifungal activity against 
different Candida species.19,31 Results from toxicologic assays 
have shown no in vitro cytotoxicity of nano-Ag nanoparticles 
in concentrations sufficient to inhibit microbial growth,18,32 
but at high concentrations, nano-Ag do exert cytotoxic effects 
on human mesenchymal stem cells.33 More and more results 
provide evidence for a molecular mechanism of nano-Ag 
activity, showing that nano-Ag act through reactive oxygen 
species generation,29 leading to activation of proteins and 
inducing apoptosis via the mitochondrial pathway.34 In vivo 
measurements in chicken embryos and quails demonstrated 
that hydrocolloids of nano-Ag at the level of 50 ppm did 
not affect development or cause oxidative DNA damage to 
embryos35 or growth of quails.36
Gold nanoparticles (nano-Au) are well established 
carriers for delivery of double-stranded DNA in gene gun 
technology.37 It has been demonstrated that nano-Au can 
localize in tumors by passive accumulation, because of the 
enhanced permeability and retention effect in the leaky ves-
sels of tumors.38–41 The process of targeting by nano-Au can 
minimize treatment durations and side effects of drugs.42,43
The antimicrobial activity of platinum has been known 
since the work of Rosenberg, who reported its inhibitory 
activity on Escherichia coli division.44 Cisplatin and other 
derivatives synthesized from platinum have been used in cancer 
treatment, and act by forming adducts with DNA and impairing 
DNA synthesis and repair.45 Recently, analysis of the morpho-
logic effects of interaction between platinum nanoparticles 
(nano-Pt) and S. enteritidis revealed that nano-Pt were located 
inside bacteria cells, demonstrating that these cells might be 
used to deliver nano-Pt and attach active substances to specific 
targets in the body, as discussed previously.23
Diamond nanoparticles (nano-D) are highly biocom-
patible and nontoxic to human cells.46,47 Furthermore, the 
antioxidative properties of nano-D, via redox pathways, 
could improve the local environment of treatment areas 
in the body.48 It has also been demonstrated that nano-D 
inhibit genotoxic and cellular stress at the molecular level 
in humans.49 Nano-D can be applied as drug-sequestering 
elements, and have exciting prospects, including adjustable 
and extended time release of the active substance.50 Accord-
ingly, in histopathologic and ultrastructural investigations 
after intratracheal administration of nano-D in mice, no 
adverse effects in the lungs were noticed. Furthermore, no 
lipid peroxidation of the lung was observed.51
In a previous paper,23 we indicated that shortly after mix-
ing nano-Pt with S. enteritidis, nano-Pt penetrated bacterial 
cells and remained inside the bacteria, even after washing 
and centrifugation, and that the average number of bacterial 
cells with nano-Pt did not change after prolonged incubation. 
These observations indicate that the complexes, visualized 
shortly after mixing, are stable, and that the interaction can 
be observed directly in real time and with minimized chemi-
cal (handling of the sample) interference. Consequently, in 
the present investigation, the characteristics of self-assembly 
were observed immediately after mixing nanoparticles with 
microorganisms. The objective was to identify additional can-
didates for constructing microorganism–nanoparticle vehicles 
to deliver active substances to specific targets in the body. The 
examined compounds were S. aureus and C. albicans, together 
with nanoparticles of diamond, silver, gold, and platinum.
Materials and methods
Nanoparticles
Diamond nanoparticles were obtained from the Biomedical 
Engineering Division, Technical University of Łódz ´. Nano-D International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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was produced by the method described by Danilenko52 with 
modification of ampoule-free synthesis with explosions in 
the explosion chamber. Graphite was placed directly into 
a cylindrical charge consisting of a TNT-hexogen mixture 
TG40; the charge was enveloped in a water jacket to suppress 
graphitization and to reduce the unloading rate of the syn-
thesized diamond.53 For experiments with   microorganisms, 
nano-D was suspended in Milli-Q water (Millipore, Billerica, 
MA) at a concentration of 50 ppm. Shape and size of nano-
particles were evaluated using a JEM-2000EX transmission 
electron microscope (TEM) at 200 keV (JEOL, Tokyo, 
Japan), showing that the size of particles ranged from 2 to 
10 nm (Figure 1).
Hydrocolloids of silver, gold, and platinum nanoparticles 
(50 ppm) obtained from Nano-Tech (Warsaw, Poland) were 
produced by an electric nonexplosive patented method 
  (Polish Patent 3883399) from high purity metals (99.9999%) 
and high purity demineralized water. Shape and size of nano-
particles were inspected by TEM (Figure 1), showing that 
the diameter of the particles was 2–35 nm for Ag, 2–29 nm 
for Au, and 2–19 nm for Pt.
The zeta potential of hydrocolloids of nanoparticles 
and microorganisms was measured by the electrophoretic 
light-scattering method,54 using a Zetasizer Nano ZS, model 
ZEN3500 (Malvern Instruments, Worcestershire, UK). 
Each sample was measured after 120 seconds of stabili-
zation at 25°C, in 20 replicates. The mean zeta potential 
was -9.2 mV (nano-Ag), -1.9 mV (nano-Au), -9.6 mV 
(nano-Pt), and +27 mV (nano-D). The microorganisms had 
zeta potentials between -20 and -27 mV.
Microorganisms
Strains were obtained from LGC Standards (Lomianki, 
Poland). Bacteria strain S. aureus ATCC 25923 was grown on 
trypto–casein–soy agar (BioRad, San Francisco, CA). Fungi 
strain C. albicans ATCC 24433 was grown on Sabouraud agar 
(BTL, Lód , Poland). Microorganisms were gently washed out 
from the agar using sterile distilled water. To remove the liquid 
remains of the medium, bacteria were centrifuged at 4000 rpm 
for five minutes using an Eppendorf MiniSpin centrifuge and 
the sediment (pellet) was resuspended in Milli-Q water. To 
calculate the exact number of microorganisms in the suspen-
sion, the optical density at 600 nm (OD600) was estimated by 
spectrophotometer (Helios Epsilon, Unicam; Thermo Spec-
tronic, Madison, WI), and serial dilutions of the suspension 
were prepared. One milliliter of each dilution was transferred 
Figure 1 Nanoparticles of diamond, silver, gold, and platinum.International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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to Petri dishes with agar. After 24 hours of incubation at 37°C, 
the number of colonies was estimated. According to the results 
of triple measurements, the density of microbial suspension 
OD600 = 0.140 corresponded to 1.95 × 108 cfu/mL and at 
OD600 = 0.182 corresponded to 7.3 × 107 cfu/mL for S. 
aureus and C. albicans, respectively.
Method of observation
Hydrocolloids of each kind of nanoparticle (200 µL) were 
separately added to the microorganism suspensions (200 µL). 
Control samples of microorganisms were treated with 
  Milli-Q water. The samples were gently mixed for 15 minutes 
and then droplets of samples were put on Formvar-coated 
300 mesh Cu grids (Agar Scientific Ltd, Stansted, UK). In 
this way, the inspected object was observable after a very 
short time of interaction of nanoparticles with the living 
microorganisms. The samples were dried at room tempera-
ture, in sterile conditions, and observed using a JEM-2000EX 
TEM at 200 keV (JEOL). The applied voltage was chosen 
to avoid any damage to the sample. The method developed 
enabled direct observation of the initial interface between 
nanoparticles and microorganisms, particularly including 
visualization of small amounts of a substance excreted from 
the microorganisms.
Results
Examination of the control microorganisms indicated some 
changes caused by the applied methods (centrifugation, 
Milli-Q water, drying), but did not show any toxicologic or 
destructive alteration (Figure 2).
The morphology of interaction between nano-D and 
S. aureus is presented in Figure 3. Nano-D were attached 
nonspecifically to the cell wall, showing affinity for the 
  peptidoglycan layer. Nano-D could be seen also within the 
cell and cell wall. When nano-D interacted with C. albicans, 
it was observed that diamond also attached and surrounded 
the cells very closely. Nano-D was gathered by the released 
substance, probably cytoplasm (Figure 4).
The image of morphologic effects of nano-Ag and 
S. aureus assembling (Figure 5) indicates that nano-Ag 
were located at given points on the bacterial cell. They 
caused gaps and made the cell release some of the 
substances to which they adsorbed. The morphologic effect 
of interaction between nano-Ag and C. albicans was quite 
similar   (Figure 6). Cells became distorted, and nano-Ag 
disintegrated and disrupted the cell wall and cytoplasmic 
membrane and a substence (probably cytoplasm) was 
leaking from the fungi cells.
Nano-Au did not surround S. aureus but were trapped 
within the biofilm produced by the cell (Figure 7). Nano-Au 
disintegrated the cell wall and the cytoplasmic membrane of 
C. albicans. However, they were not seen around the fungal 
cells. Cells and their clusters were surrounded by released 
inhomogeneous matter, containing droplets of different 
electron density. Nano-Au appeared to be attached to a fila-
mentous substance, probably excreted from the disrupted 
cells (Figure 8).
Nano-Pt caused S. aureus to release substances and simi-
larly disintegrated the cytoplasmic membrane and the cell 
wall, as did the other metal nanoparticles (Figure 9). Nano-Pt 
disintegrated the cell wall and cytoplasmic membrane also in 
C. albicans and stimulated release of some substances, which 
leaked from the cells (Figure 10). The cell wall seemed to 
be loosened and separated from the cytoplasmic membrane. 
Interestingly, the nanoparticles appeared to be surrounded 
by matter different from the released substance.
Figure 2 Staphylococcus aureus and Candida albicans. None of the toxicologic or destructive effects of the procedure can be seen.International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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Discussion
In the present investigation, different chemical and physical 
properties of diamond and metal nanoparticles were con-
firmed when they came into contact with living organisms. 
They exhibited various effects on bacteria and fungi.
We could observe a clear link between zeta potential and 
the electron structure of the nanoparticles and their interaction 
with microorganisms. Nano-D are dielectrics and exhibit a 
positive zeta potential, being very different from the mem-
brane potential of microorganisms, and uniformly surrounded 
the microorganisms, without causing visible damage and 
destruction of the cells (Figures 3 and 4).
In the case of C. albicans, glucan and chitin, both 
microfibrillar polysaccharides, are cellular components that 
confer rigidity to the overall cell wall structure, and appear 
to be more concentrated in the inner cell wall layer, adjacent 
to the plasma membrane. In the outermost cell wall layer, 
proteins and mannoproteins appear to predominate,55 and 
nano-D could possibly bind them closely, without visible 
cell destruction.
All metal nanoparticles with negative zeta potential, ie, 
less than the zeta potential of bacterial cells, showed cell-
damaging properties. However, their behaviors were differ-
ent, in that silver showed the properties of self-organization 
Figure 3 Interaction between Staphylococcus aureus and diamond nanoparticles. 
Arrows indicate nanoparticles nonspecifically attached to the microorganisms.
Figure 4 Interaction between Candida albicans and diamond nanoparticles. Arrows 
indicate nanoparticles surrounding cells very closely.International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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with the cells, disintegrating the cell walls and cytoplasmic 
membranes, and releasing a substance (probably cytoplasm) 
outside the cell. The released substance was strongly con-
nected with nano-Ag, indicating possible chemisorption of 
the substance to nano-Ag (Figure 5).
Nano-Ag, when evaluated for their antimicrobial activity 
against Gram-positive and Gram-negative bacteria, showed 
high antibacterial activity against both types of bacteria, 
including highly multiresistant strains, such as S. aureus.56,57 
Antifungal activity of nano-Ag29–31,56 has been also suggested 
in the present investigation. The results suggest that nano-Ag 
may exert a fungicidal activity by destroying cell membrane 
integrity (Figure 6). Other results30 have also shown that 
fungal cells treated with nano-Ag show significant damage, 
characterized by the formation of a pit in their cell walls and 
pores in their plasma membrane.
In the case of nano-Pt, it is difficult to assess whether 
self-assembling occurred, since activity of Pt was violent, 
causing an outflow of a substance outside the cells, probably 
due to damaged walls and cell membranes (Figures 9 and 10). 
This is in agreement with our previous results regarding self-
assembling between nano-Pt and S. enteritidis, showing that 
Figure  5  Interaction  between  Staphylococcus  aureus  and  silver  nanoparticles. 
Arrows indicate nanoparticles located at specific points on the cells, attached to the 
substance released by microorganisms.
Figure 6 Interaction between Candida albicans and silver nanoparticles. White arrows 
indicate nanoparticles attached to the substance released by microorganisms. Black 
arrows indicate distorted cells, a disintegrated cell wall, and cytoplasmac membrane.International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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nano-Pt disintegrated bacterial cell walls and cytoplasmic 
membranes.23
Compared with nano-Ag and nano-Pt, nano-Au showed 
different effects on bacteria and fungi cells. Arrangement 
of nano-Au with microorganisms did not create a system 
of self-organization. However, a “noncontact” interaction 
between nanoparticles and microorganisms caused damage to 
fungal cells (Figure 8) and probably a defensive reaction on 
the part of the bacterial cells (Figure 7). The impact of gold 
could be explained by ion emission from the nanoparticles 
in an aqueous environment. Moreover, it is very interesting 
that the interaction with nano-Au is not the same as with 
nano-Ag. It could be expected that interactions occurring 
would be similar, because both kinds of nanoparticles should 
bind the same chemically active groups on the surface of the 
cell. However, the interaction observed was different for these 
two kinds of nanoparticles.
The present observations indicate that the contact between 
metal nanoparticles (nano-Ag, nano-Au, and nano-Pt) 
and microorganisms promote chemical interactions that 
are harmful to the microorganism. However, dielectric 
nano-D, with high, positive zeta potential, appear to be 
Figure 7 Interaction between Staphylococcus aureus and gold nanoparticles. White 
arrows indicate nanoparticles trapped by the biofilm and the substance released by 
cells. Black arrow indicates distorted cell wall.
Figure  8  Interaction  between  Candida  albicans  and  gold  nanoparticles.  Arrows 
indicate the substance of different electron density released by cells.International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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chemically   nonaggressive, and create consistent systems of 
self-assembly with microorganisms. This observation could 
be an important guideline for selection of applications of 
nanoparticles as antimicrobial compounds and/or as carriers 
of active   medical substances.
The application of TEM visualization provides an 
extraordinary opportunity for the morphologic evaluation 
of ongoing interactions between microorganisms and nano-
particles. Unfortunately, using this technique, it was not 
possible to identify chemical bonds between the two com-
ponents. As mentioned earlier, the interface between them 
is very specific as well for the types of   microorganisms and 
  nanoparticles. It can only be speculated what kind of microor-
ganism   envelope is involved in the interaction, and this needs 
further investigation using specific staining methods.
Conclusion
Nano-Ag, nano-Au, and nano-Pt (metal nanoparticles) are 
harmful to bacteria and fungi. Nano-Ag attach specifically 
to the microbial cell wall, evoke the release of a substance 
from the microorganisms, and bind to it. Nano-Au act in 
a   “noncontact” way, stimulate biofilm production, and 
  aggregate within this biofilm. Nano-Pt damage cell walls 
and cause the release of a substance leaking from the cells. 
Figure 9 Interaction between Staphylococcus aureus and platinum nanoparticles. 
Arrows indicate nanoparticles and the substance released by cells.
Figure 10 Interaction between Candida albicans and platinum nanoparticles. Black 
arrows indicate nanoparticles surrounded by the released substance. White arrows 
indicate the cell wall loosened and separated from the membrane or disrupted.International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
Dovepress 
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Unlike metal nanoparticles, nano-D bind closely to the 
  surface of the microorganisms without causing visible dam-
age to the cells, indicating good self-assembling ability. The 
results indicate that both microorganisms could potentially 
be used as carriers for nano-D.
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